World wide shipping
Medicines from all over the world
We will help you find any drug in 24 hours
Prices for medicines are presented for informational purposes only

Afinitor (everolimus) 10 mg 30 tab NOVARTIS Switzerland

Article:
In Stock
0 $
658 $
+
Description
Interchangeable drugs with the same active ingredient:
  • Afinitor
  • Evertor
  • Evertor

Indications

  • Treatment in combination with exemestane of advanced hormone receptor-positive, HER2-negative breast cancer in postmenopausal women who do not have Rapidly progressive visceral disease, if previous therapy with non-steroidal aromatase inhibitors has led to relapse or progression.
  • Treatment of patients with advanced renal cell carcinoma whose disease progresses on or after VEGF therapy (targeting vascular endothelial growth factor).
  • Treatment of unresectable or metastatic, well or moderately differentiated pancreatic neuroendocrine tumors in adult patients with progressive disease.
  • Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) requiring therapeutic intervention other than surgery.
  • Evidence of the effectiveness of treatment are changes in the amount of SEGA. No further clinical outcome, such as improvement in disease-related symptoms, was found.
  • Treatment of adult patients with renal angiomyolipomas associated with the tuberous sclerosis complex (TSC) in which there is a risk of complications (eg, tumor size, aneurysm, multiple tumors, or bilateral tumors) that do not require surgery.
  • Evidence of the effectiveness of treatment is the analysis of changes in the total volume of angiomyolipomas.
Features
  • Commercial name:
    Afinitor
  • Сhemical name:
    Everolimus
  • Dosage:
    10 mg
  • Quantity:
    thirty
  • Release form:
    Tablets
Reviews
Наталия
Очень довольна результатом Вашей работы , обслуживание качественное, препараты всегда получаем без задержки. Всем рекомендую !!!! Спасибо Вам за хорошую работу ))
Write Review
Name*
Email
Write a Review*